Browsing by Author Moreau, Philippe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroupJoshua, Douglas; Chng, W-J; Dimopoulos, Meletios A; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Hajek, Roman; Ludwig, Heinz; Moreau, Philippe; Niesvizky, R.; Pour, Ludek; Central Clinical School: MedicineCarfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup, Leukemia & Lymphoma, vol.58, 10, 2017,pp 2501-2504
2017Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORJoshua, Douglas; Chng, W-J; Dimopoulos, Meletios A; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Ludwig, Heinz; Moreau, Philippe; Niesvizky, R.; Palumbo, Antonio; Pour, Ludek; Central Clinical School: MedicineCarfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR, Leukemia, vol.31, 6, 2017,pp 1368-1374
2017Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyJoshua, Douglas; Chng, W-J; et al, Various; Facon, Thierry; Goldschmidt, Hartmut; Hajek, Roman; Ludwig, Heinz; Moreau, Philippe; Niesvizky, R.; Palumbo, Antonio; Pour, Ludek; Central Clinical School: MedicineImpact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study, Leukemia, vol.31, 1, 2017,pp 115-122